$939 Million is the total value of Novo Holdings A/S's 22 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INGN | INOGEN INC | $275,285,000 | +15.5% | 3,549,320 | 0.0% | 29.31% | +29.1% | |
| ANAB | New | ANAPTYSBIO INC | $84,180,000 | – | 3,033,504 | +100.0% | 8.96% | – |
| RETA | REATA PHARMACEUTICALS INCcl a | $76,280,000 | +3.8% | 3,367,763 | 0.0% | 8.12% | +16.0% | |
| IRTC | IRHYTHM TECHNOLOGIES INC | $76,119,000 | +25.3% | 2,024,448 | 0.0% | 8.11% | +40.1% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $66,963,000 | +45.2% | 3,224,046 | 0.0% | 7.13% | +62.4% | |
| RARX | RA PHARMACEUTICALS INC | $43,252,000 | +40.2% | 2,031,562 | 0.0% | 4.61% | +56.7% | |
| XLRN | Buy | ACCELERON PHARMA INC | $41,133,000 | +30.0% | 1,553,937 | +25.3% | 4.38% | +45.3% |
| FLXN | FLEXION THERAPEUTICS INC | $37,613,000 | +41.5% | 1,397,718 | 0.0% | 4.00% | +58.2% | |
| MRUS | MERUS N V | $34,400,000 | +15.5% | 1,410,417 | 0.0% | 3.66% | +29.2% | |
| SPNC | SPECTRANETICS CORP | $34,342,000 | +18.9% | 1,179,122 | 0.0% | 3.66% | +32.9% | |
| OBSV | New | OBSEVA SA | $31,689,000 | – | 3,044,093 | +100.0% | 3.37% | – |
| NBRV | NABRIVA THERAPEUTICS AG | $27,919,000 | +101.3% | 2,326,544 | 0.0% | 2.97% | +125.1% | |
| DERM | Buy | DERMIRA INC | $25,522,000 | +288.6% | 748,240 | +245.5% | 2.72% | +334.9% |
| KALV | KALVISTA PHARMACEUTICALS INC | $22,664,000 | +10.5% | 2,901,927 | 0.0% | 2.41% | +23.5% | |
| APEN | APOLLO ENDOSURGERY INC | $18,241,000 | +3.0% | 1,456,972 | 0.0% | 1.94% | +15.1% | |
| AKBA | New | AKEBIA THERAPEUTICS INC | $11,705,000 | – | 1,272,247 | +100.0% | 1.25% | – |
| IVTY | INVUITY INC | $10,482,000 | +38.3% | 1,318,448 | 0.0% | 1.12% | +54.6% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS INC | $8,859,000 | +208.9% | 1,280,185 | 0.0% | 0.94% | +245.4% | |
| WMGIZ | WRIGHT MED GROUP N Vright 03/01/2019 | $7,072,000 | +15.9% | 4,622,032 | 0.0% | 0.75% | +29.6% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $4,862,000 | +7.5% | 223,317 | 0.0% | 0.52% | +20.2% | |
| XENE | XENON PHARMACEUTICALS INC | $510,000 | -48.1% | 127,563 | 0.0% | 0.05% | -42.6% | |
| OPK | OPKO HEALTH INC | $2,000 | 0.0% | 259 | 0.0% | 0.00% | – | |
| VGK | Exit | VANGUARD INTL EQUITY INDEX Fftse europe etf | $0 | – | -2,101,000 | -100.0% | -9.59% | – |
| CLCD | Exit | COLUCID PHARMACEUTICALS INC | $0 | – | -3,156,563 | -100.0% | -10.94% | – |
| VTI | Exit | VANGUARD INDEX FDStotal stk mkt | $0 | – | -1,623,100 | -100.0% | -17.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.